This inventor holds 1 USPTO granted patent. Top assignee: Laila Pharmaceuticals Pvt. Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Dwarakanath Anjana: Innovator in Nanoformulations
Introduction
Dwarakanath Anjana is a notable inventor based in Vijayawada, India. He has made significant contributions to the field of nanoformulations, particularly focusing on hydrophobic plant-derived compounds. His innovative work has the potential to enhance the bioavailability and effectiveness of various compounds in pharmaceutical applications.
Latest Patents
Dwarakanath holds a patent for a highly bioavailable, water-soluble, and sustained release nanoformulation of hydrophobic plant-derived compounds and extracts. This formulation is designed to provide a sustained release of the hydrophobic compounds over a 24-hour period. The patent describes a process for preparing this water-soluble nanoformulation, which is a significant advancement in the field.
Career Highlights
He is currently associated with Laila Pharmaceuticals Pvt. Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in nanoformulations has positioned him as a valuable asset to his company and the broader scientific community.
Collaborations
Dwarakanath has collaborated with notable colleagues such as Ravichandran Sripathy and Venkata Narasimha Siva Rama Raju Mandapati. These collaborations have further enriched his research and development efforts.
Conclusion
Dwarakanath Anjana's contributions to the field of nanoformulations exemplify the impact of innovative thinking in pharmaceuticals. His work not only advances scientific knowledge but also holds promise for improving therapeutic outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile